✦ LIBER ✦

A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic assessment of velafermin in patients with active oral mucositis

✍ Scribed by J. Mehta; M.W. Schuster; J. Harpel; B. Skikne; T. Shore; S. Duffey; J. Greenberg; C. Divine; Y. Halvorsen; C. Cosentino; W. Hahne

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II multicenter study to assess t

✍ H. M. Kantarjian, S. Padmanabhan, W. Stock, M. S. Tallman, G. A. Curt, J. Li, A. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 188 KB

A phase I trial assessing the safety, to

✍ J. Scheele; K. Diergarten; J. Drevs; F. R. Niazi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Phase I Study to Assess the Safety, Tole

✍ Taito Esaki; Takashi Seto; Hiroshi Ariyama; Shuji Arita; Chinatsu Fujimoto; Koic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

926 Pharmacokinetics (PK), clinical phar

✍ J.H.M. Schellens; J.R. Eckardt; D.D. von Hoff; G.J. Creemers; C. Gerrits; W.J. L 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase I safety, pharmacokinetic, and pha

✍ Markman, B.; Tabernero, J.; Krop, I.; Shapiro, G. I.; Siu, L.; Chen, L. C.; Mita 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 362 KB

A phase I/II dose escalating trial evalu

✍ P. Marcellin; G.K.K. Lau; H. Mommeja-Marin; S. Sacks; D. Sereni; J.P. Bronowicki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB